“Specialty Drugs”

39 result(s)
Doctor and patient in clinic, viewing notes on a tablet
Care Management
Oncologists need to take in an enormous amount of information to provide their patients with the most up-to-date treatment. CVS Specialty is partnering with NCCN to provide... More
Briefing
Male patient holding a pill bottle and glass of water
Cost Management
CVS Caremark’s QALY-based program aims to bring rationality to drug pricing using comparative effectiveness research and cost-effectiveness analysis, and get manufacturers to set... More
Commentary
Mother and daughter playing in living room
Care Management
Cancer therapy is evolving and new treatments are being developed at an almost breakneck pace. To help better manage care and costs for oncology, CVS Health has developed an... More
Briefing
Senior couple walking on a beach
Specialty
CVS Health’s three-tier specialty formulary design separates the increasingly more expensive specialty therapies into three distinct copay or coinsurance categories. Paired with... More
Briefing
Nurse and patient viewing prescription information on a laptop computer
Specialty
PAH is a rare, life-threatening disease, which is incurable. It is difficult to manage and to help ensure the longest survival and best possible quality of life, members need... More
Briefing
Two female pharmaceutical scientists working in a lab
Drug Pipeline
When the FDA approves a “supplemental indication” for a drug already on the market — permitting it to be used for new conditions or stages of a disease, or additional patient... More
Briefing
Portrait photo of Jon Roberts speaking at the CVS Health Forum
Cost Management
Our formulary strategies effectively leverage competition in the pharmaceutical market to help reduce costs and trend for PBM clients. More
Video
Male scientist filling liquid drug samples into vials
Drug Pipeline
Scientific developments are altering the pace and focus of specialty drug development, while regulatory changes are shortening approval times. This poses new challenges for payors... More
Briefing
Doctor with stethoscope, checking a patient's breating
Specialty
While the launch time is uncertain, potential PAH generics could give payors greater cost control opportunities for a complex, expensive condition requiring lifelong treatment. More
Briefing
Female lab scientist filling a vial with a liquid sample
Specialty
Gene therapies bring hope for patients with conditions with few or no treatments, but also other considerations including safety and cost. More
Feature